Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole vs Itraconazole in Pityriasis Versicolor
NCT06922344Phase 4Recruiting
- Sponsor
- Khyber Teaching Hospital
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in pityriasis versicolor comparing Fluconazole Group with Itraconazole Group (2 arms). Primary endpoint: Efficacy of Treatment at 8 weeks. Started Mar 2025; status: recruiting.
02
Drugs
fluconazoleitraconazole
03
Conditions
pityriasis versicolor
Beyond the preview
Go deeper on NCT06922344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06922344.